Fen Saj, Research Fellow at MD Anderson Cancer Center, shared on LinkedIn:
“Happy to share our review, now published in JCO Journals JCO Oncology Practice, with Camila Xavier, Lipika Goyal, Milind Javle, and Shubham Pant.
Cholangiocarcinoma is rising in incidence and remains highly challenging to treat. In this review, aimed at practicing clinicians, we focus on the latest advances, including newer targeted therapy options and locoregional treatment approaches.”
Title: Personalized Therapy in Advanced Cholangiocarcinoma: Contemporary Treatment Approaches and Future Directions
Authors: Fen Saj, Camila Braganca Xavier, Lipika Goyal, Milind Javle, Shubham Pant
Read the Full Article
FDA Approved Lirafugratinib for FGFR2 Fusion or Rearrangement–Positive Cholangiocarcinoma
